Gelonghui May 16 丨 Jiabiyou (688089nightdrawing.SH) said on the investor interaction platform that the company takes technological innovation as the fundamental driving force, has opened up the entire technology chain of synthetic biology, and gradually formed its core technical capabilities with computational biology and bioinformatics.nightdrawingbiological data analysis and processing platform with genetic engineering, metabolic engineering, enzyme engineering, and cell engineering as its core technical capabilitiesnightdrawingThe biosynthesis platform of the company is a functional verification platform with cell biology, biomedicine, and multi-dimensional omics visual analysis as its core capabilities. From product development to application technology, the company's synthetic biology research and development technical capabilities have been further improved. Based on synthetic biology technology, the company has currently developed a series of HMO products.
